NSC |
Compound |
Enrichment |
Correlation |
NSC 357704 |
Cyanomorpholinodoxorubicin |
0.00220234298765534 |
0.07774095 |
NSC 643006 |
Null |
0.00220234298765537 |
0.14626678 |
NSC 728091 |
6-[(3-Hydroxy)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8,9-methy lenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.00220234298765537 |
0.23653303 |
NSC 677945 |
Quinoline-5,8-dione, 6-[(3-hydroxy-3-phenyl-2-propyl)amino]- |
0.00298819091754573 |
0.13636166 |
NSC 691215 |
Null |
0.00298819091754573 |
0.2117999 |
NSC 619031 |
Analog of CC-1065 |
0.00311751113090891 |
0.13126985 |
NSC 721386 |
5-Fluoro-2'-deoxyuridyl 2-(1,4-naphthoquinonyl)methyl N-methyl-N-(4-chlorobutyl) phosphoramidate |
0.00311751113090891 |
0.17081566 |
NSC 76919 |
2-Pyridinecarboxylic acid, 5-amino-6-(7-amino-1,2,3,4,5,8-hexahydro- 5,8-dioxo-2-quinolinyl)-4-(2-hydroxy- 3,4-dimethoxyphenyl)-3-methyl- |
0.00311751113090891 |
0.22293529 |
NSC 271967 |
Methanaminium, N-[4-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.00314218974141796 |
0.055808205 |
NSC 663790 |
Null |
0.00314218974141796 |
0.09494194 |